Chromogranin-A Expression as a Novel Biomarker for Early Diagnosis of Colon Cancer Patients

Colon cancer is one of the major causes of cancer death worldwide. The five-year survival rate for the early-stage patients is more than 90%, and only around 10% for the later stages. Moreover, half of the colon cancer patients have been clinically diagnosed at the later stages. It is; therefore, of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xueli, Zhang, Hong, Shen, Bairong, Sun, Xiao-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628020/
https://www.ncbi.nlm.nih.gov/pubmed/31207989
http://dx.doi.org/10.3390/ijms20122919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628020/
https://www.ncbi.nlm.nih.gov/pubmed/31207989
http://dx.doi.org/10.3390/ijms20122919

Ejemplares similares